ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) for BOEING COMPANY
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 22, 2024 | $50,000 | Replaced |
| 4th Quarter - Termination | Apr 15, 2024 | $50,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
- HR 3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 (the PATIENT Act) - HR 4507, Transparency in Coverage Act - HR 4822, Health Care Price Transparency Act - HR 5378, Lower Costs, More Transparency Act - HR 5688, Bipartisan HSA Improvement Act - General health care and employee benefits issues: Health care coverage; regulatory implementation; transparency, delivery and payment reform; cost containment and telehealth; proposals related to ERISA preemption - H.R. 1843, S. 1001 - Telehealth Expansion Act of 2023 - H.R. 824 - the Telehealth Benefit Expansion for Workers Act of 2023 - S. 628, H.R. 3029 - the Primary Care Enhancement Act of 2023 - S. 1339 - Pharmacy Benefit Manager Reform Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TARA BRADSHAW | — |
| HEATHER MEADE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.